Delhi High Court restrains Cipla from infringing Novartis’ respiratory drug

Upholding Justice Manmohan Singh’s order of January 2015, the division bench of Badar Durrez Ahmed and Sanjeev Sachdeva, JJ. of the Delhi High Court today restrained Cipla from infringing Novartis’ patent on its drug Indacaterol – marketed under the name “Onbrez”.

Loading content, please wait...

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com